Janux Therapeutics (JANX) on late Monday reported positive updated interim data for its JANX007, a PSMA-directed TRACTr, Phase 1 clinical program in patients with metastatic castration-resistant ...
Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or ...
The latest update is out from Apogee Therapeutics ( (APGE)). On November 10, 2025, Apogee Therapeutics announced positive interim Phase 1 results for APG333, which exceeded trial objectives and ...
Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva/Gazyvaro, an anti-CD20 monoclonal antibody designed for enhanced B cell depletion Gazyva/Gazyvaro has the potential to ...
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in ...
Hosted on MSN
PepGen Inc. Announces Positive Phase 1 Study Results
Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. PepGen Inc. ( (PEPG)) has issued an ...
LOS ANGELES--(BUSINESS WIRE)--Pelage Pharmaceuticals, a clinical-stage regenerative medicine company, today announced positive results from its Phase 2a clinical trial of PP405 — a topical therapy for ...
Moderna's messenger RNA flu vaccine candidate has shown has shown positive results in a late-stage trial. The biotechnology company said Monday its seasonal influenza vaccine candidate, mRNA-1010, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. She presented 12-month results of three participants who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback